Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jul 28.
doi: 10.1002/gcc.22887. Online ahead of print.

MLLT10 rearranged acute leukemia: Incidence, prognosis, and possible therapeutic strategies

Michelle O Forgione  1   2 , Barbara J McClure  1   3 , David T Yeung  1   3   4 , Laura N Eadie  1   3 , Deborah L White  1   2   3   5   6
Affiliations
Review

MLLT10 rearranged acute leukemia: Incidence, prognosis, and possible therapeutic strategies

Michelle O Forgione et al. Genes Chromosomes Cancer. .

Abstract

Rearrangements of the MLLT10 gene occur in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL), most commonly T-lineage ALL (T-ALL), in patients of all ages. MLLT10 rearranged (MLLT10r) acute leukemia presents a complex diagnostic and therapeutic challenge due to frequent presentation of immature or mixed phenotype, and a lack of consensus regarding optimal therapy. Cases of MLLT10r AML or T-ALL bearing immature phenotype are at high risk of poor outcome, but the underlying molecular mechanisms and sensitivity to targeted therapies remain poorly characterized. This review addresses the incidence and prognostic significance of MLLT10r in acute leukemia, and how the aberrant gene expression profile of this disease can inform potential targeted therapeutic strategies. Understanding the underlying genomics of MLLT10r acute leukemia, both clinically and molecularly, will improve prognostic stratification and accelerate the development of targeted therapeutic strategies, to improve patient outcomes.

Keywords: AF10; MLLT10; MLLT10 rearrangements; leukemia genomics; t(10;11)(p12-13;q14-21).

PubMed Disclaimer

References

REFERENCES

    1. Beverloo H, Le Coniat M, Wijsman J, et al. Breakpoint heterogeneity in t(10;11) translocation in AML-M4/M5 resulting in fusion of AF10 and MLL is resolved by fluorescent in situ hybridization analysis. Cancer Res. 1995;55(19):4220-4224.
    1. Abdelali R, Asnafi V, Petit A, et al. The prognosis of CALM-AF10-positive adult T-cell acute lymphoblastic leukemias depends on the stage of maturation arrest. Haematologica. 2013;98(11):1711-1717.
    1. Borel C, Dastugue N, Cances-Lauwers V, et al. PICALM-MLLT10 acute myeloid leukemia: a French cohort of 18 patients. Leuk Res. 2012;36(11):1365-1369.
    1. Alexander TB, Gu Z, Iacobucci I, et al. The genetic basis and cell of origin of mixed phenotype acute leukaemia. Nature. 2018;562(7727):373-379.
    1. Khurana S, Melody ME, Ketterling RP, et al. Molecular and phenotypic characterization of an early T-cell precursor acute lymphoblastic lymphoma harboring PICALM-MLLT10 fusion with aberrant expression of B-cell antigens. Cancer Genet. 2020;240:40-44.